Acute Continuous Renal Replacement Therapy

1. Front Matter

   Pages i-xv

   PDF

2. Ultrafiltration/Hemofiltration Overview: Where Does CAVH Fit?

   • L. Henderson

   Pages 1-5

3. Continuous Replacement Modalities in Acute Renal Dysfunction

   • E. Paganini

   Pages 7-41

4. Transport in Continuous Arteriovenous Hemofiltration and Slow Continuous Ultrafiltration

   • M. Lysaght, D. Boggs

   Pages 43-50

5. The Practical Technical Aspects of Slow Continuous Ultrafil Tration (SCUF) and Continuous Arteriovenous Hemofiltration (CAVH)

   • S. Swann, E. Paganini

   Pages 51-77

6. Fluid Balance in Continuous Arteriovenous Hemofiltration

   • H. Schurek

   Pages 79-89

7. Hemofiltration and Ultrafiltration: Nursing Concerns

   • G. Whitman

   Pages 91-111

8. Hyperalimentation in Acute Renal Failure

   • E. Feinstein

   Pages 113-122

9. Continuous Arteriovenous Hemofiltration — the Control of Azotemia in Acute Renal Failure

   • C. Olbricht

   Pages 123-141

10. The Predilution Mode for Continuous Arteriovenous Hemofil Tration

    • A. Kaplan

    Pages 143-172

11. Nutrition in Acute Renal Failure: Treatment Made Possible by Continuous Arteriovenous Hemofiltration (CAVH)

    • R. Bartlett

    Pages 173-183

12. Drug Kinetics and Continuous Arteriovenous Hemofiltration

    • T. Golper

    Pages 185-199

13. Continuous Arteriovenous Hemofiltration in Infants

    • C. Ronco

    Pages 201-245

14. Continuous Arteriovenous Hemodialysis — Laboratory Experience and Theory

    • H. Bregman, T. Ing

    Pages 247-253

15. Continuous Arteriovenous Hemodialysis — Clinical Experience

    • R. Geronemus, N. Schneider

    Pages 255-267

16. Continuous Ambulatory Peritoneal Dialysis in Acute Renal Failure

    • M. Schreiber

    Pages 269-282

17. Continuous Arteriovenous Hemofiltration —Applications other than for Renal Failure

    • E. Wolner

    Pages 283-292

The initial observations of dialytic support were brought from the laboratory and confined to patients with reversible acute renal failure. The thought at that time was one of short term maintenance. It was theorized that removal of waste products from the blood, albeit incomplete and inefficient, might allow these patients time to regenerate damaged tubules and regain renal function. After a dis­ appointing earlier experience in survival, greater sophisti­ cation and broader practice refined the dialysis skills and reduced mortality. It also became apparent that long periods of support were possible and successful attempts were then made in utilizing this technology in patients with chronic renal failure. These early young patients were a very select group who possessed only renal dysfunction and no other systemic involvement. Nonetheless, they demonstrated a one year survival of only 55-64%. There are presently over 80,000 patients on dialytic support in the United States and over 250,000 patients worldwide dependent on artificial replace­ ment. Mortality statistics vary but despite a 20-30% systemic disease involvement and a fifth decade average age in the North American experience, the one year survival has risen to apparently 90%.

• Laboratory
• age
• blood
• dialysis
• drug
• hemodialysis
• kinetics
• mortality
• nursing
• nutrition
• renal failure
• statistics
• therapy
• transport
• treatment

• Department of Hypertension and Nephrology, The Cleveland Clinic Foundation, Cleveland, USA

  Emil P. Paganini

Policies and ethics